drugset / Trial / NCT06816823
CAR-NK Cells (CL-NK-001) in Pancreatic Cancer
NaSingle-groupOpen-labelTreatment
Summary
This is a single-center, open-label, first-in-human, dose-escalation study in patients with pancreatic cancer.
Timeline
- Start
- 2025-04-07
- Primary completion
- 2025-09
- Completion
- 2025-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CL-NK-001 | Cell therapy | 5e+08 cells | — |
| Subject | CL-NK-001 | Cell therapy | 1.5e+09 cells | — |
| Subject | CL-NK-001 | Cell therapy | 3e+09 cells | — |